Severe Acute Respiratory News and Research

RSS

St. John's wort extract shows potent antiviral activity against SARS-CoV-2 and its variants

Scientists from Germany have recently identified Hypericum perforatum, a widespread herbal plant known as St. John's wort, as a potential antiviral agent against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The study is published in the journal Pharmaceuticals.

27 Apr 2022

Research highlights importance of booster vaccine doses to protect against all Omicron variants

In a recent study published in the Cell Host and Microbe journal, researchers examined the neutralization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron BA.1, BA.1.1, and BA.2 sublineages.

27 Apr 2022

Research looks at children hospitalized with SARS-CoV-2 who depend on medical technology

In a recent study posted to the Research Square* preprint server, researchers described coronavirus disease 2019 (COVID-19) infection in technology-dependent children.

27 Apr 2022

Chromogranin A plasma levels increase in COVID - predict mortality

A recent paper posted to the Public Library of Science (PLOS) ONE journal showed that plasma levels of chromogranin A (CgA) could predict death in coronavirus disease 2019 (COVID-19) patients.

27 Apr 2022

Superior T-cell immunity in COVID vaccinated

A recent study published in the journal Public Library of Science (PLOS) ONE presented the T cell and humoral immune responses following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infection against the SARS-CoV-2 original and mutant strains.

27 Apr 2022

Fourth dose of COVID vaccine in over 60 years significantly effective

In a recent study published in the Nature Medicine journal, the researchers assessed the effectiveness of a second booster dose of the BioNTech, Pfizer BNT162b2 vaccine against coronavirus disease 2019 (COVID-19) severity in elderly patients.

26 Apr 2022

Asymptomatic SARS-CoV-2 infection among research personnel: Study

A recent research paper published in the journal Public Library of Science (PLOS) ONE analyzed asymptomatic coronavirus disease 2019 (COVID-19) in personnel engaged in academic study.

26 Apr 2022

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

A new study examined the protective effect of the mRNA booster vaccine against the SARS-CoV-2 Omicron variant in 21-month-old mice.

26 Apr 2022

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Researchers assessed the binding pocket of linoleic acid, an essential free-fatty acid in the receptor-binding domains of the spike protein of beta-coronaviruses.

26 Apr 2022

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Researchers developed a highly pathogenic mouse-adapted SARS-CoV-2 strain to model mild, moderate, or COVID-19.

26 Apr 2022

Evidence of increased intrinsic cleavability of SARS-CoV-2 Omicron spike protein by host cell furin

Researchers conducted an in vitro analysis to assess the host cell furin-mediated cleavability of the spike protein of the SARS-CoV-2 Omicron (B.1.529) variant.

26 Apr 2022

Characteristics of viral infection super-spreaders

Researchers evaluated whether certain super-spreaders transmit viral infection better and the impacts of individual variance in epidemiological characteristics.

26 Apr 2022

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Researchers identified a nanobody inhibiting SARS-CoV-2 variants.

26 Apr 2022

Clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization

Researchers presented the clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization.

26 Apr 2022

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

The researchers assessed immunological and pathophysiological aspects of antenatal COVID-19.

26 Apr 2022

The potency of halicin against the main protease of SARS-CoV-2

A new paper published in Current Research in Chemical Biology discusses the potential of a molecule called halicin against SARS-CoV-2.

26 Apr 2022

Severe Acute Respiratory News and Research

St. John's wort extract shows potent antiviral activity against SARS-CoV-2 and its variants

Research highlights importance of booster vaccine doses to protect against all Omicron variants

Research looks at children hospitalized with SARS-CoV-2 who depend on medical technology

Chromogranin A plasma levels increase in COVID - predict mortality

Superior T-cell immunity in COVID vaccinated

Fourth dose of COVID vaccine in over 60 years significantly effective

Asymptomatic SARS-CoV-2 infection among research personnel: Study

mRNA booster vaccination found to protect aged mice against the Omicron variant of SARS-CoV-2

Free fatty acid-binding pocket found to be preserved across spike proteins of beta coronaviruses

Researchers use mouse model to explore correlation of impaired interferon-mediated immune response with severe COVID-19

Evidence of increased intrinsic cleavability of SARS-CoV-2 Omicron spike protein by host cell furin

Characteristics of viral infection super-spreaders

Nanobody effectively neutralizes pseudotyped ancestral SARS-CoV-2 and Omicron spike proteins

Clinical traits with inflammation characterization of long COVID and correlation with one-year recovery after COVID-19-linked hospitalization

Study explores SARS-CoV-2 antibody responses in mild COVID-19 cases

The response of four SARS-CoV-2 spike variants to linoleic acid removal

Quantum dot biomimetic for SARS-CoV-2 examines neurovascular dysregulation related to brain inflammation

Effectiveness of CoronaVac, AZD1222, and BNT162b2 vaccine boosters

Durability and neutralization capacity of SARS-CoV-2 specific antibodies in the breastmilk of convalescent COVID-19 mothers

The potency of halicin against the main protease of SARS-CoV-2

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News